Number of documents

4

Olivier Colliot - Research Director at CNRS - ARAMIS Lab (CNRS/INRIA/Inserm/UPMC)


Research Director at CNRS

 

Head of the ARAMIS Lab, a joint team between CNRSInriaInserm and University Pierre and Marie Curie at the Brain and Spine Institute (ICM), in co-direction with Didier Dormont.

 


"Geoffroy Gagliardi"   

Journal articles2 documents

  • Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, et al.. Reduction of recruitment costs in preclinical AD trials. Validation of automatic pre-screening algorithm for brain amyloidosis. Statistical Methods in Medical Research, SAGE Publications, 2019, pp.096228021882303. ⟨10.1177/0962280218823036⟩. ⟨hal-01964942v2⟩
  • Bruno Dubois, Stéphane Epelbaum, Francis Nyasse, Hovagim Bakardjian, Geoffroy Gagliardi, et al.. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurology, Elsevier, 2018, 17 (4), pp.335 - 346. ⟨10.1016/S1474-4422(18)30029-2⟩. ⟨hal-01777834⟩

Conference papers2 documents

  • Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, et al.. Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trials. Multimodal Learning for Clinical Decision Support, Sep 2017, Quebec City, Canada. ⟨hal-01578422⟩
  • Stephane Epelbaum, Anne Bertrand, Aline Mendes, Marc Levy, Geoffroy Gagliardi, et al.. Suspected non-alzheimer disease pathophysiology (SNAP) categorization in the insight cohort. AAIC, 2016, Toronto, Canada. pp.P1073 - P1074, ⟨10.1016/j.jalz.2016.06.2246⟩. ⟨hal-01562646⟩